ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2024 Earnings Call Transcript February 26, 2025
ACADIA Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.86, expectations were $0.13.
Operator: Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Conference Call. My name is Shannon, and I will be your coordinator for today. I would now like to turn the presentation over to Al Kildani, Senior Vice President of Investor Relations and Corporate Communications...
